Apoptosis, proliferation, and Fas (APO-I, CD95)/Fas ligand expression in medullary carcinoma of the breast

被引:0
|
作者
Yakirevich, E
Maroun, L
Cohen, O
Izhak, OB
Rennert, G
Resnick, MB
机构
[1] Lady Davis Carmel Med Ctr, Dept Pathol, IL-34362 Haifa, Israel
[2] Rambam Med Hosp, Dept Pathol, Haifa, Israel
[3] Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel
[4] Lady Davis Carmel Med Ctr, Dept Surg, IL-34362 Haifa, Israel
[5] Lady Davis Carmel Med Ctr, Dept Community Med & Epidemiol, IL-34362 Haifa, Israel
关键词
breast; medullary carcinoma; apoptosis; TUNEL; proliferation; PCNA; Fas; FasL;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Medullary carcinoma (MC) of the breast is a unique subtype of infiltrating ductal carcinoma that is characterized by a prominent lymphoid infiltrate and improved prognosis. Activated granzyme B+/CD8(+) cytotoxic T-lymphocytes (CTLs) infiltrating tumour cell nests constitute a major subset within the lymphoid infiltrate. As CTLs destroy target tumour cells by triggering apoptosis, it mould be of interest to determine whether the apoptotic rate in MC is increased. This study evaluates the extent of apoptosis in relation to Fas (APO-1, CD95)/Fas ligand (FasL) expression in MC. Fourteen cases of typical MC (TMC) and 15 cases of atypical MC (AMC) classified according to the Ridolfi criteria, as well as 19 cases of poorly differentiated infiltrating ductal carcinoma (PDC) were evaluated. The apoptotic index (AI) was assessed by the TUNEL method on paraffin-embedded tissue. Cell proliferation was evaluated immunohistochemically by PCNA staining. The level of Fas/FasL expression was determined semiquantitatively by immunohistochemistry using a four-grade scoring system. The AI was significantly increased in TMC and AMC as opposed to the PDC subgroup (2.2 +/- 0.8, 2.1 +/- 0.8, and 1.3 +/- 0.6, respectively; p < 0.05). A significant proportion (31.8 +/- 7.9% in TMC and 25.8 +/- 9.7% in AMC) of the apoptotic tumour cells within tumour nests mere in close contact with CD3(+) lymphocytes. Increased apoptosis was not accompanied by increased proliferation of tumour cells. The extent of Fas expression did not differ between the three subgroups. FasL was expressed both by tumour infiltrating lymphocytes in MC and by tumour epithelium in all three subgroups. The observation that the majority of MCs express Fas and are infiltrated by lymphocytes expressing FasL suggests that increased apoptosis in MC is mediated by Fas/FasL. However, our observation that the majority of MCs also express Fast and the fact that tumours co-expressing Fas and FasL did not show increased apoptosis suggest that there may be additional cytotoxic pathways that lead to tumour apoptosis in MC. Copyright (C) 2000 John Wiley & Sons, Ltd.
引用
收藏
页码:166 / 173
页数:8
相关论文
共 50 条
  • [1] Fas/CD95/Apo-I activates the acidic sphingomyelinase via Caspases
    Brigit Brenner
    Klaus Ferlinz
    Heike Grassmé
    Michael Weller
    Ursula Koppenhoefer
    Johannes Dichgans
    Konrad Sandhoff
    Florian Lang
    Erich Gulbins
    Cell Death & Differentiation, 1998, 5 : 29 - 37
  • [2] Fas/CD95/Apo-I activates the acidic sphingomyelinase via caspases
    Brenner, B
    Ferlinz, K
    Grassmé, H
    Weller, M
    Koppenhoefer, U
    Dichgans, J
    Sandhoff, K
    Lang, F
    Gulbins, E
    CELL DEATH AND DIFFERENTIATION, 1998, 5 (01) : 29 - 37
  • [3] Expression of Fas (CD95/APO-1) and Fas Ligand (FasL) in Experimentally-Induced Acute Pancreatitis
    Pardalis, Vassilios
    Palli, Eleni
    Lambropoulou, Maria
    Tsigalou, Christina
    Anagnostoulis, Stavros
    Garoufalis, Grigorios
    Bolanaki, Helen
    Simopoulos, Constantinos
    Karayiannakis, Anastasios J.
    JOURNAL OF INVESTIGATIVE SURGERY, 2014, 27 (02) : 65 - 72
  • [4] Expression of Fas (APO-1/CD95) and Fas ligand (FasL) in human neuroblastoma
    Gross, N
    Balmas, K
    Brognara, CB
    Tschopp, J
    MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 36 (01): : 111 - 114
  • [5] Somatic mutations in the death domain of the Fas (Apo-I/CD95) gene in gastric cancer
    Park, WS
    Oh, RR
    Kim, YS
    Park, JY
    Lee, SH
    Shin, MS
    Kim, SY
    Kim, PJ
    Lee, HK
    Yoo, NJ
    Lee, JY
    JOURNAL OF PATHOLOGY, 2001, 193 (02) : 162 - 168
  • [6] Increased expression of Fas (CD95/APO-I) in adult rat brain after kainate-induced seizures
    Tan, ZQ
    Levid, J
    Schreiber, SS
    NEUROREPORT, 2001, 12 (09) : 1979 - 1982
  • [7] Enhancement of T cell apoptosis correlates with increased serum levels of soluble Fas (CD95/Apo-I) in active lupus
    Silvestris, F
    Grinello, D
    Tucci, M
    Cafforio, P
    Dammacco, F
    LUPUS, 2003, 12 (01) : 8 - 14
  • [8] Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes
    D Bouscary
    J De Vos
    M Guesnu
    K Jondeau
    F Viguier
    J Melle
    F Picard
    F Dreyfus
    M Fontenay-Roupie
    Leukemia, 1997, 11 : 839 - 845
  • [9] Fas/Apo-1(CD95) expression and apoptosis in patients with myelodysplastic syndromes
    Bouscary, D
    DeVos, J
    Guesnu, M
    Jondeau, K
    Viguier, F
    Melle, J
    Picard, F
    Dreyfus, F
    FontenayRoupie, M
    LEUKEMIA, 1997, 11 (06) : 839 - 845
  • [10] Fas receptor (CD95) & Fas ligand (CD 178) expression in patients with tobacco-related intraoral squamous cell carcinoma
    Das, Satya N.
    Khare, Pratima
    Singh, Manoj K.
    Sharma, Suresh C.
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2011, 134 (01) : 54 - 60